KIR2DS2 Antibody

Code CSB-PA012360LA01HU
Size US$299Purchase it in Cusabio online store
(only available for customers from the US)
Image
  • Immunohistochemistry of paraffin-embedded human lymph node tissue using CSB-PA012360LA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human skin tissue using CSB-PA012360LA01HU at dilution of 1:100

  • Immunofluorescent analysis of A549 cells using CSB-PA012360LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name Rabbit anti-Homo sapiens (Human) KIR2DS2 Polyclonal antibody
Uniprot No. P43631
Target Names KIR2DS2
Alternative Names KIR2DS2; CD158J; NKAT5; Killer cell immunoglobulin-like receptor 2DS2; CD158 antigen-like family member J; MHC class I NK cell receptor; NK receptor 183 ActI; Natural killer-associated transcript 5; NKAT-5; p58 natural killer cell receptor clone CL-49; p58 NK receptor CL-49; CD antigen CD158j
Raised in Rabbit
Species Reactivity Human
Immunogen Recombinant Human Killer cell immunoglobulin-like receptor 2DS2 protein (104-241AA)
Immunogen Species Homo sapiens (Human)
Conjugate Non-conjugated

The KIR2DS2 Antibody (Product code: CSB-PA012360LA01HU) is Non-conjugated. For KIR2DS2 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA012360LB01HU KIR2DS2 Antibody, HRP conjugated ELISA
FITC CSB-PA012360LC01HU KIR2DS2 Antibody, FITC conjugated
Biotin CSB-PA012360LD01HU KIR2DS2 Antibody, Biotin conjugated ELISA
Clonality Polyclonal
Isotype IgG
Purification Method >95%, Protein G purified
Concentration It differs from different batches. Please contact us to confirm it.
Buffer Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form Liquid
Tested Applications ELISA, IHC, IF
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
IF 1:50-1:200
Protocols ELISA Protocol
Immunohistochemistry (IHC) Protocol
Immunofluorescence (IF) Protocol
Troubleshooting and FAQs Antibody FAQs
Storage Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Receptor on natural killer (NK) cells for HLA-C alleles. Does not inhibit the activity of NK cells.
Gene References into Functions
  1. Genotypes missing these two inhibitory KIR-HLA combinations in addition to missing activating KIRs 2DS2 and 2DS3 were more common in Vogt-Koyanagi-Harada disease (OR = 1.90, P = 0.002). PMID: 27490240
  2. KIR2DS2/HLA-C1 may correlate with Hashimoto thyroiditis in a Chinese population. PMID: 27042744
  3. Loss of KIR2DS2 gene is associated with breast cancer. PMID: 27631728
  4. association between KIR2DS2 and the response to methotrexate (MTX), moreover, the combination KIR2DL2+/KIR2DS2+ was more frequent in responders to MTX (p = 0.043). PMID: 27251940
  5. this study shows that the presence of KIR2DS2 was associated with a worsening of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies PMID: 27394130
  6. genetic polymorphism is associated with childhood acute lymphoblastic leukemia among north Indians PMID: 26472014
  7. this study was to look for immunogenetic determinants in the pathogenesis of FMF and find out if KIR are related to susceptibility. An activator KIR gene, KIR2DS2, was significantly more frequent in FMF patients (p=0.036). PMID: 26574972
  8. a significant increase in the frequency of KIR2DL2 (P = 0.019) as well as KIR2DS2 (P = 0.008) in patients with neuroblastoma compared with the healthy control group, was found. PMID: 26202659
  9. Single Nucleotide Polymorphism in KIR2DS2 gene is associated with Asthma and Atopic Dermatitis. PMID: 26430804
  10. genetic polymorphism is associated with chronic hepatitis C and levels of viremia in Poland PMID: 25636579
  11. KIR2DL2 and KIR2DS2 genotype is associated with protection against primary biliary cirrhosis in Han population. PMID: 25575065
  12. CD4(+) CD28(-) cells exhibited increased KIR2DS2, reduced KIR2DL3 and increased DAP12 expression in HD-ESRD compared with NDD-CKD patients. PMID: 25484131
  13. Authors showed a significant increased correlation between KIR2DL2/DS2, type 2 diabetes and HLA-C1C1 genotype in the type 2 diabetes patients infected with human herpesvirus 8. PMID: 24122895
  14. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival. PMID: 25381437
  15. There is an association of the KIR2DS gene, especially KIR2DS2, with psoriatic arthritis. PMID: 24185760
  16. Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11. PMID: 24550293
  17. Analysis of this large cohort from Uganda in the context of other African populations reveals variations in KIR and HLA-C1 and C2 that are consistent with migrations within Africa and potential selection pressures on these genes. PMID: 23974321
  18. Data indicate that increased frequency of the activating receptor KIR2DS1 and a reduced frequency of the KIR-ligand combination KIR2DS2/2DL2 absent/C1 present were significantly associated with chronic myeloid leukemia (CML). PMID: 23380384
  19. presence of KIR2DS2 is associated with rheumatoid arthritis. PMID: 22960345
  20. Our data revealed a unique contribution of activating KIRs (KIR2DS4, KIR2DS2, or KIR3DS1), in addition to NKG2C, in the expansion of human natural killer cells. PMID: 23325834
  21. in response to HCT therapy, the activating receptors are also enhanced by a process that increases the number of unmethylated sites present on KIR2DS2/4 promoters. PMID: 22939905
  22. The frequency of the combination of HLA-C1 allele group with KIR2DS2 was significantly higher in severe dry eye disease patients. PMID: 22509813
  23. individuals possessing KIR2DL2 and/or KIR2DS2 (and, in most cases, also KIR2DL1) gene but no HLA-C C2 ligand may respond better to treatment and survive longer than people bearing other genotypes. PMID: 22836042
  24. KIR2DS2/KIR2DL2 and HLA-C genotype of rheumatoid arthritis patients may provide predictive information for response to anti-TNF-alpha therapy. PMID: 21373785
  25. In a comparison of healthy controls and a tightly defined cohort of adult ITP patients, the KIR2DS2/KIR2DL2 genotype was found to be associated with ITP independently of FCGR3a-158 polymorphisms. PMID: 22024796
  26. The CMV seropositivity of donors was not associated with activating KIR expression, and donor null expression in those with the KIR2DS2 or KIR2DS4 genotype was not predictive for CMV reactivation in the recipient. PMID: 21596150
  27. This study showed a significantly lower frequency of KIR2DS2 among chronic HCV carriers compared with controls in a Korean population PMID: 22065905
  28. KIR2DS2*005 encodes a molecule expressed on the surface of natural killer- and T-lymphocytes. PMID: 21593779
  29. predisposition to systemic lupus erythematosus was associated with GTGT deletion at the SLC11A1 3'UTR, presence of KIR2DS2 +/KIR2DS5 +/KIR3DS1 + profile, increased number of stimulatory KIR genes and European and Amerindian ancestries PMID: 21233146
  30. indicated nonspecific stimulation of natural killers, probably mediated by an increase in serum concentration of heat shock protein with a molecular weight of 70 kDa PMID: 21165439
  31. Observational study of gene-disease association. (HuGE Navigator) PMID: 20878400
  32. an evolutionary trend toward reducing the avidity of the activating C1- and C2-specific receptors is exempllified by KIR2DS2, an activating C1-specific receptor that has lost all detectable avidity for HLA class I. PMID: 20802150
  33. Observational study of gene-disease association. (HuGE Navigator) PMID: 20528243
  34. Observational study of gene-disease association. (HuGE Navigator) PMID: 20580654
  35. Observational study of gene-disease association. (HuGE Navigator) PMID: 20600442
  36. Observational study of gene-disease association. (HuGE Navigator) PMID: 20643584
  37. Observational study of genotype prevalence. (HuGE Navigator) PMID: 20650299
  38. Observational study of gene-disease association. (HuGE Navigator) PMID: 20652381
  39. Observational study of genotype prevalence. (HuGE Navigator) PMID: 20670355
  40. Observational study of gene-disease association. (HuGE Navigator) PMID: 20137308
  41. Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) PMID: 20356536
  42. Observational study of gene-disease association. (HuGE Navigator) PMID: 20371502
  43. Observational study of gene-disease association. (HuGE Navigator) PMID: 20426625
  44. Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) PMID: 20483367
  45. Observational study of gene-disease association. (HuGE Navigator) PMID: 20492596
  46. Observational study of gene-disease association. (HuGE Navigator) PMID: 20519398
  47. Single nucleotide polymorphism in KIR2DS2 gene is associated with posttransplantation non-Hodgkin lymphoma. PMID: 20207982
  48. Observational study of gene-disease association. (HuGE Navigator) PMID: 19683555
  49. Observational study of gene-disease association. (HuGE Navigator) PMID: 19968064
  50. Observational study of gene-disease association. (HuGE Navigator) PMID: 20082482

Show More

Hide All

Subcellular Location Cell membrane; Single-pass type I membrane protein.
Protein Families Immunoglobulin superfamily
Database Links

HGNC: 6334

OMIM: 604953

KEGG: hsa:100132285

UniGene: Hs.512572

Newsletters

Get all the latest information on Events, Sales and Offers. Sign up for newsletter today.

© 2007-2022 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1